Hypomethylating agents-venetoclax as salvage therapy for relapse of AML and MDS after allogeneic HCT. uri icon

authors

  • Samuels, Diana T
  • Ali, Haris
  • Salhotra, Amandeep
  • Aldoss, Ibrahim
  • Koller, Paul
  • Aribi, Ahmed
  • Sandhu, Karamjeet
  • Andrew Artz, MD, MS
  • Smith, Eileen
  • Stewart, Forrest
  • Becker, Pamela
  • Ball, Brian J
  • Al Malki, Monzr M
  • Stein, Anthony
  • Marcucci, Guido
  • Forman, Stephen J
  • Nakamura, Ryotaro
  • Pullarkat, Vinod
  • Tsai, Ni-Chun
  • Otoukesh, Salman
  • Arslan, Shukaib
  • Pourhassan, Hoda
  • Blackmon, Amanda
  • Agrawal, Vaibhav
  • Amanam, Idoroenyi

publication date

  • June 12, 2026